Delivery Order SPE2DB20D7059-SPE2DB25FGSC3
Award Date 9/13/25
Potential Completion Date 9/15/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,846.41 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cryselle-28 is an oral contraceptive...
- This is a $19,107.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for CRYSELLE-28 TABLET 28S medical supplies, with a period of performance ending on February 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a ceiling value of $1,867.56 and a performance period ending on June 17, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- This is a $2,183.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a medical product, with a period of performance through April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg contraceptive medication in a 28-day supply. This competitive, non-set-aside delivery order carries a ceiling value of $3,290.16 under firm fixed price terms, with an ultimate completion date of September 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,437.99 for Junel FE 1 mg-20 mcg tablets (28-count), a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.56 to AmerisourceBergen Drug Corp for NORTREL 0.5-35-28 Tablet 28S, a contraceptive medication. The contract was awarded on August 14, 2025, under firm fixed-price terms with an ultimate completion date of August 15, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,887.09, is a firm fixed price delivery order for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...